Paul Lau is a corporate associate in the New York office of Latham & Watkins and a member of the Capital Markets Practice.

Mr. Lau represents corporates, financial institutions, and private equity firms on a wide range of equity and debt capital markets and corporate finance transactions, as well as general corporate and securities law matters.

These include initial public offerings, follow-on and secondary equity offerings, investment grade, high-yield and convertible debt offerings, liability management transactions, corporate governance issues, public company reporting obligations, and stock exchange rules and requirements.

Mr. Lau has experience working across jurisdictions, including in Hong Kong, London, and New York.

Mr. Lau maintains an active pro bono practice, representing non-profits and individuals seeking asylum.

Mr. Lau served on the board of the Hong Kong Schools Debating and Public Speaking Community, Limited, and was a member of both the Welsh and Hong Kong national schools debate teams.

Mr. Lau's experience includes advising:

Debt Capital Markets

  • American Airlines in its US$750 million senior secured notes offering
  • Broadcom in its US$6 billion exchange offer for senior notes, US$750 million senior notes offering, and US1.2 billion exchange offer for senior notes
  • Morgan Stanley as initial purchaser in the US$400 million green convertible senior notes offering by Stem, Inc.
  • Jeffries as initial purchaser in the US$200 million convertible senior notes offering by Danimer Scientific
  • Investment banks, as lenders or initial purchasers, in Hertz's car rental securitizations
  • Xiaomi in its US$600 million senior notes offering*
  • Medco Energi in its US$300 million senior notes offering and US$500 million senior notes offering*

Equity Capital Markets

  • Morgan Stanley as underwriter in the US$88.5 million initial public offering of AirSculpt Technologies
  • Global-e in its US$883 million secondary offering of common stock
  • Trip.com in its US$1.1 billion offering of ordinary shares and secondary listing in Hong Kong*
  • Bairong in its US$500 million initial public offering and listing in Hong Kong*
  • ZTO Express in its US$1.25 billion offering of Class A ordinary shares and secondary listing in Hong Kong*
  • Everest Medicines in its US$451 million initial public offering and listing in Hong Kong*
  • Cathay Media and Education Group in its US$184 million initial public offering and listing in Hong Kong*
  • Edvantage Group in its US$91 million initial public offering and listing in Hong Kong*
  • China Renaissance in its US$350 million initial public offering and listing in Hong Kong*
  • China Literature Limited in its US$1.06 billion spin-off from Tencent Holdings via an initial public offering and listing in Hong Kong*

*Matter handled prior to joining Latham

Bar Qualification

  • Hong Kong (Solicitor)
  • New York

Education

  • Postgraduate Certificate in Laws, University of Hong Kong
  • BA, University of Oxford